{"id":4413,"date":"2019-03-26T03:03:58","date_gmt":"2019-03-26T03:03:58","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4413"},"modified":"2020-11-03T20:48:56","modified_gmt":"2020-11-03T20:48:56","slug":"dabrafenib-and-trametinib-in-treating-patients-with-erdheim-chester-disease-with-braf-v600-mutations","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/de\/study_trials\/dabrafenib-and-trametinib-in-treating-patients-with-erdheim-chester-disease-with-braf-v600-mutations\/","title":{"rendered":"Dabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 Mutations"},"content":{"rendered":"<p><strong>Ziel der Studie:&nbsp; <\/strong>This phase II trial investigates the efficacy and safety of dabrafenib and trametinib treatment in patients with Erdheim Chester disease that have BRAF V600 gene mutations.<br \/>\n<strong>Sponsor:<\/strong>&nbsp; National Cancer Institute (NCI)<br \/>\n<strong>Kontaktdaten f\u00fcr die Testphase:<\/strong>&nbsp; Study Coordinator: Ms. Abha Adat, aadat@mdanderson.org, or the Principal Investigator Filip Janku, 713-563-1930, FJanku@mdanderson.org.<br \/>\n<strong>Gew\u00fcnschte Einbeziehung des Patienten:<\/strong>&nbsp; ECD patients with BRAF V600 mutation who have not previously been treated with a BRAF- or MEK-inhibitor and are 18-years or older.<br \/>\n<strong>Bekannte Zentren, die ECD-Patienten in die Studie aufnehmen:<\/strong>&nbsp; MD Anderson, Houston, Texas<br \/>\n<strong>ClinicalTrials.gov-Kennung:<\/strong>&nbsp; NCT03794297<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective:&nbsp; This phase II trial investigates the efficacy and safety of dabrafenib and trametinib treatment in patients with Erdheim Chester disease that have BRAF V600 gene mutations. Sponsor:&nbsp; National [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[32],"class_list":["post-4413","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-drug-trial"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/de\/wp-json\/wp\/v2\/study_trials\/4413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/de\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/de\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/de\/wp-json\/wp\/v2\/media?parent=4413"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/de\/wp-json\/wp\/v2\/study_trials_cat?post=4413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}